Detail akcie Alphatec Holdings online

Business Summary: Alphatec Holdings, Inc., through its wholly owned subsidiaries, Alphatec Spine, Inc., EOS imaging S.A.S. and SafeOp Surgical, Inc., is a medical device company. The Company is focused on the design, development, and advancement of technology for better surgical treatment of spine disorders. The Company's Organic Innovation Machine is focused on developing new approaches that integrate with its expanding Alpha InformatiX (AIX) Platform to better inform surgery and safely and reproducibly achieve the goals of spine surgery. Its technologies include AIX, positioners, access systems, implants and fixation systems, and biologics. Its AIX product platform comprises its EOS imaging system and VEA alignment mobile application, its SafeOp Neural InformatiX System and its navigation-enabled robotics platform (Valence). It has developed approach-specific patient positioning systems that integrate with its other access systems, providing for a more rigid construct and enhanced reproducibility.
Financial Summary: BRIEF: For the fiscal year ended 31 December 2025, Alphatec Holdings Inc revenues increased 25% to $764.2M. Net loss decreased 12% to $143.4M. Revenues reflect United States segment increase of 25% to $716.1M, International segment increase of 19% to $48M. Lower net loss reflects Design and development surgical treatement segment loss decrease of 40% to $82.1M. Basic Earnings per Share excluding Extraordinary Items increased from -$1.13 to -$0.96.